Advances in PCR Technology and Its Applications in Healthcare Research
Breaking Through Barriers between Benchtop and Bedside
Cannibalism: A Biological and Evolutionary Perspective
Sounds of Science Podcast
Ubiquitin System: The Next Class of Drug Targets?
A Complex Role in Cellular Process & Growing Tool Set to Elucidate It
Bispecific Antibodies Close in on Cancer
Plotting Molecular Pincer Movements, Denying Cancer Room to Maneuver
Seth Lederman, M.D., is co-founder, CEO, and chairman of Tonix Pharmaceuticals.
More GEN Content From This Contributor:
- Columns: Drug Repurposing Rekindles Promise